Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Accelerated Access Review

This page shows the latest Accelerated Access Review news and features for those working in and with pharma, biotech and healthcare.

Abivax’s COVID-19 study declared Research National Priority by French government

Abivax’s COVID-19 study declared Research National Priority by French government

Those clinical trials, including Abivax’s study, that are declared to be a national priority gain access to an accelerated regulatory review and approval process by the French regulatory authorities (ASNM) ... Results from the ongoing study are

Latest news

  • Novartis links up with NHS for speedy access to cholesterol drug inclisiran Novartis links up with NHS for speedy access to cholesterol drug inclisiran

    Novartis has teamed up with the UK’s NHS in a novel partnership which will see patients receive accelerated access to its groundbreaking cholesterol-lowering drug inclisiran. ... The Department of Health and Social care has not revealed the agreed

  • Ex-GSK head Witty to head group overseeing UK fast-track scheme Ex-GSK head Witty to head group overseeing UK fast-track scheme

    be selected for the Government’s new Accelerated Access Pathway (AAP), due to come into effect next April. ... Last October, the independent Accelerated Access Review (AAR) led by Sir High Taylor set out a series of recommendations for streamlining the

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    The NHS is interested in managing access, not in blocking it," he said adding that NICE and pharma were "in the same business". ... The Strategy also made a series of recommendations that would overlap with and supplement the Accelerated Access Review,

  • Mixed news for pharma on UK's Accelerated Access Review Mixed news for pharma on UK's Accelerated Access Review

    The scheme is the first stage in the independent Accelerated Access Review (AAR) - designed to accelerate patient access to new medicines and devices in the UK - that was published last October. ... It set out a series of recommendations for streamlining

  • NICE to bring HTA processes to mobile health apps NICE to bring HTA processes to mobile health apps

    Its evaluations will build on the Paperless 2020 simplified app assessment process - as recommended in the recent Accelerated Access Review - to create a “digital infrastructure [that] should enable the system to ... The app is currently available on

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    Alongside this, rumours that NHS England was planning to include biosimilars on the Accelerated Access Pathway, the flagship policy intervention designed to speed up the use of innovative products, would amount ... Sciences Industrial Strategy and the

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... Specifically, this should include building on the recommendations put forward in the Life Science Industrial Strategy and the Accelerated

  • Macron, Merkel and May: implications of the 2017 elections for the life science industry Macron, Merkel and May: implications of the 2017 elections for the life science industry

    The ABPI has pursued legal action, arguing that this contravenes the NHS Constitution, which legally entitles patients access to NICE-approved treatments. ... Furthermore, the 2017 Conservative Party election manifesto promised to ‘implement the

  • Lighting the way Lighting the way

    How the UK’s Accelerated Access Review aims to guide medical innovations to their destination. ... She noted that engaging with the government on the new Life Sciences Strategy (see p7) and the Accelerated Access Review were among NICE's top priorities

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    In October 2016, the Accelerated Access Review (AAR) published its recommendations to the UK government. ... Furthermore, not all of these technologies would necessarily complete the Accelerated Access Pathway.

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest from PMHub

  • Aurora celebrates 15 years of improving lives Aurora celebrates 15 years of improving lives

    Claire Eldridge, CEO, comments: “It has been a privilege to work with our clients to help realise the potential of their interventions, to ensure patient access to innovation and to promote ... Worked to speed up access to innovative medicines and

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
Springer Nature

Operating in 50+ countries, we’re a leading research, educational, and professional publisher dedicated to advancing scientific discovery. Whether you’re looking...

Latest intelligence

Patient Clinical Trial & Communications Plan Review: A Customer Story
...
Working together to achieve better patient pathways
Digital tools can supercharge patient treatment and outcomes but the importance of the patient voice cannot be underestimated...
Design-thinking. Iterating for continuous improvement.
How design can lead improvement within Pharma...

Quick links